Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction

Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction

US Patent 6548490 · Granted Apr 15, 2003

Estimated economic value: $2,445,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of cardiovascular disease using ActRII ligand traps2023
Activin-ActRII antagonists and uses for treating bone and other disorders2019
Treatment of female sexual dysfunction with vasoactive intestinal polypeptide ag2007
Co-administration of a prostaglandin and an androgenic agent in the treatment of2003
Co-administration of a prostaglandin and an androgenic agent in the treatment of2003
Method for minimizing excess collagen deposition2002
Method for minimizing excess collagen deposition2002
Treatment of female sexual dysfunction using phosphodiesterase inhibitors2002
Treatment of female sexual dysfunction using phosphodiesterase inhibitors2002
Administration of phosphodiesterase inhibitors for the treatment of premature ej2002
Administration of phosphodiesterase inhibitors for the treatment of premature ej2002
Administration of phosphodiesterase inhibitors for the treatment of premature ej2002